SCHEMBL895802

SCHEMBL895802

CC(C)C[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccc(-c2cc3cc(NC(=O)C4CCCN4C(=O)[C@H](CC(C)C)N(C)C)ccc3[nH]2)cc1)N(C)C

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.42
ALDH1A1 P00352 2/20 0.40
GAA P10253 1/20 0.40
HCRTR1 O43613 1/20 0.40
HCRTR2 O43614 1/20 0.40
SLC2A1 P11166 1/20 0.39
CYP3A4 P08684 5/20 0.39
CYP2C9 P11712 5/20 0.39
CYP2C19 P33261 5/20 0.39
CYP2D6 P10635 2/20 0.39
CYP1A2 P05177 2/20 0.39
KCNQ2 O43526 1/20 0.39
EP300 Q09472 2/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HTT P42858 1/20 0.38
STAT3 P40763 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL895804 1.00 KCNH2 (0.42) KCNH2ALDH1A1GAAHCRTR1HCRTR2
SCHEMBL16309238 0.95 STAT3 (0.39) KCNH2ALDH1A1GAAHCRTR1HCRTR2
SCHEMBL894831 0.93 KCNH2 (0.45) KCNH2ALDH1A1GAAHCRTR1HCRTR2
SCHEMBL16309207 0.91 KCNH2 (0.49) KCNH2ALDH1A1GAAHCRTR1HCRTR2
SCHEMBL17044980 0.87 PSMB8 (0.36) KCNH2ALDH1A1GAAHCRTR1HCRTR2
SCHEMBL894832 0.82 KCNH2 (0.39) KCNH2ALDH1A1GAAHCRTR1HCRTR2
SCHEMBL24731012 0.82 HCRTR1 (0.41) KCNH2ALDH1A1GAAHCRTR1HCRTR2
SCHEMBL895154 0.81 KCNH2 (0.46) KCNH2ALDH1A1GAAHCRTR1HCRTR2
SCHEMBL27966125 0.81 KCNH2 (0.49) KCNH2ALDH1A1GAAHCRTR1HCRTR2
SCHEMBL30065583 0.81 KCNH2 (0.49) KCNH2ALDH1A1GAAHCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150246917-A1 INHIBITORS OF HEPATITIS C VIRUS REPLICATION MERCK SHARP & DOHME CORP. (US) 2015-09-03 US disclosed
US-8871759-B2 Inhibitors of hepatitis C virus replication MERCK SHARP & DOHME CORP. (US) 2014-10-28 US disclosed
US-20120083483-A1 INHIBITORS OF HEPATITIS C VIRUS REPLICATION MERCK SHARP & DOHME CORP (NJ) 2012-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120083483-A1 INHIBITORS OF HEPATITIS C VIRUS REPLICATION HAVCR2, HCCS, EIF2AK2 KCNH2 4621/4885ALDH1A1 2400/4885GAA 530/4885
US-20150246917-A1 INHIBITORS OF HEPATITIS C VIRUS REPLICATION HAVCR2, HCCS, EIF2AK2 KCNH2 4621/4885ALDH1A1 2400/4885GAA 530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.